Just a moment...
AI-powered research trained on the authentic TaxTMI database.
Launch AI Search →Powered by Weblekha - Building Scalable Websites
Press 'Enter' to add multiple search terms. Rules for Better Search
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
<h1>Product classification appeal denied for Kaolin Light IP & NF - evidence needed for correct classification under Customs Tariff Act.</h1> The Tribunal upheld the lower authorities' decision to classify the product, Kaolin Light IP & NF, under Chapter 2505.10 instead of Chapter 30 as a ... Classification of goods - Kaolin and kaolinic clays - medicament - Chapter Notes exclusion of medicaments from Chapter 25 - requirement of being put up in measured doses or packings for retail sale or for use in hospitals - evidentiary burden to prove medicament statusClassification of goods - Kaolin and kaolinic clays - medicament - Chapter Notes exclusion of medicaments from Chapter 25 - evidentiary burden to prove medicament status - Whether the appellant's product 'Kaolin Light IP & NF' is classifiable under Chapter 2505.10 or as a medicament under Chapter 30 (heading 3003.20). - HELD THAT: - The Tribunal examined Chapter 25 (heading 2505.10) and Chapter Note 2 to Chapter 25 which expressly covers kaolin and kaolinic clays. It then considered the definition of 'medicaments' under Note 2(i) to Chapter 30, which confines medicaments to (a) compounded products comprising two or more constituents for therapeutic or prophylactic uses, or (b) unmixed products suitable for such uses that are put up in measured doses or in packings for retail sale or for use in hospitals. The appellants did not plead before the lower authorities, nor produce evidence, that their product is a compounded medicament or an unmixed medicament put up in measured doses or in hospital/retail packings; on the contrary, it was admitted that the goods were sold in bulk and consist of a single constituent (kaolin). In the absence of proof that the product meets the parameters of the Chapter 30 definition, the Chapter 25 heading 2505.10 remains applicable. The Tribunal therefore upheld the lower authorities' classification under 2505.10. [Paras 5]The product is classifiable under Chapter 2505.10 and not as a medicament under Chapter 30; the lower authorities' classification is confirmed and the appeals are dismissed.Final Conclusion: The Tribunal confirmed classification of the goods as kaolin under Chapter 2505.10, rejecting the appellants' claim that the product is a medicament under Chapter 30 for want of pleading and evidentiary proof; the appeals are dismissed. Issues:Classification of product under Chapter 2505.10 or 3003.20.Analysis:The judgment pertains to the classification of a product, Kaolin Light IP & NF, under Chapter 2505.10 or 3003.20. The appellant contended that the product should be classified under Chapter 30 as a medicament, relying on Chapter Notes that exclude medicaments from Chapter 25. The appellant argued that the lower authorities' decision was incorrect. The respondent, however, argued that the product falls under 2505.10, citing relevant provisions. The Tribunal noted that Kaolin falls under Chapter 2505.10 unless proven to be a medicament under Chapter 30. The definition of medicaments in Chapter 30 requires products to contain two or more constituents mixed for therapeutic use or be unmixed products in measured doses or retail packings. The appellant failed to provide evidence supporting the product's classification as a medicament. It was acknowledged that the product was sold in bulk, not in retail packings or measured doses. Consequently, the Tribunal upheld the lower authorities' decision that the product is classified under 2505.10 and dismissed the appeals.In conclusion, the Tribunal ruled in favor of classifying the product under Chapter 2505.10 based on the lack of evidence supporting its classification as a medicament under Chapter 30. The appellant's failure to demonstrate that the product met the criteria for a medicament, such as containing multiple constituents or being packaged for retail sale or hospital use, led to the dismissal of the appeals. The judgment emphasizes the importance of providing sufficient evidence to support classification claims and adhering to the defined criteria for specific classifications under the Customs Tariff Act.